Pall Launches Single-Use Cell Harvesting Technology
By

By
Pall Corporation, a provider of filtration, separation and purification products and services, is formally introducing the Stax mAx clarification platform, a service for the economic clarification of monoclonal antibody cell…

GE Healthcare Forms Strategic Alliance for Oligonucleotide Mfg in China
By

By
GE Healthcare Life Sciences and Guangzhou RiboBio, a Guangzhou, China-headquartered oligonucleotide-based biotechnology company, have signed a pact for oligonucleotide drugs. Under the agreement, GE Healthcare will provide the instrumentation, including…

AstraZeneca, Roche, and GSK Lead Drug Approval News
By

By
A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from AstraZeneca, Roche, GlaxoSmithKline, Pfizer, and Ultragenyx. Editor’s Note: This article was updated on a continuous…

LabVantage Appoints Vice President, Sales and Marketing
By

By
LabVantage Solutions, a Somerset, New Jersey-based laboratory informatics provider, has appointed Robert T. Voelkner as vice president, sales and marketing, to oversee business planning and sales strategies as well as…

Quotient Sciences Acquires UK CDMO
By

By
Quotient Sciences, a Nottingham, UK-based contract development and manufacturing organization (CDMO), has acquired Pharmaterials, a Reading, UK-based CDMO. Quotient says it expects the acquisition to support the growth of Quotient’s…

LGM Pharma Appoints Associate Director, Business Development
By

By
LGM Pharma, an active pharmaceutical ingredient supplier, has appointed Andrew Mitrani as its associate director of business development. In that capacity, Mitrani will be responsible for growing out the business…

Halo Pharma Partners for Fixed-Dose Combination Drug Products
By

By
Halo Pharma, a Whippany, New Jersey-headquartered contract development and manufacturing organization, plans to partner with pharmaceutical companies to provide formulation technology to support the development and manufacturing of fixed-dose combination…

Nitto Avecia Advances Oligonucleotide Expansion
By

By
Nitto Avecia, a Milford, Massachusetts-headquartered provider of nucleic acid manufacturing and development services, has completed its first synthesis runs at the 1.6 mol scale at its new oligonucleotide manufacturing facility…

Avista Pharma Adds to API Manufacturing Capacity
By

By
Avista Pharma Solutions, a Durham, North Carolina-headquartered contract testing, development, and manufacturing organization, has completed facility upgrades that the company says will double the its active pharmaceutical ingredient (API) manufacturing…

FDA Addresses Drug Shortages Due to Manufacturing Disruptions in Puerto Rico
By

By
The US Food and Drug Administration (FDA) Commissioner Scott Gottlieb updated the agency’s efforts to address drug shortages resulting from manufacturing disruptions following the damage caused by recent hurricanes in…